164 related articles for article (PubMed ID: 37123148)
21. Isolation of three separate anaphylatoxins from complement-activated human serum.
Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
[TBL] [Abstract][Full Text] [Related]
22. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity.
Bröker K; Terzenbach R; Bentzien F; Lüth S; Dammermann W
J Transl Med; 2019 Jan; 17(1):6. PubMed ID: 30602374
[TBL] [Abstract][Full Text] [Related]
23. Anaphylatoxins and infectious and non-infectious inflammatory diseases.
Köhl J
Mol Immunol; 2001 Aug; 38(2-3):175-87. PubMed ID: 11532279
[TBL] [Abstract][Full Text] [Related]
24. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
25. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
26. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
27. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
Greer J
Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
[TBL] [Abstract][Full Text] [Related]
28. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the immune response by anaphylatoxins.
Morgan EL
Complement; 1986; 3(3):128-36. PubMed ID: 3542364
[TBL] [Abstract][Full Text] [Related]
30. C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations.
Sinitsyn VV; Bokchubaev ET; Mamontova AG; Ovtrakht NV; Nasonov EL; Konovalov GA; Kukharchuk VV
Artif Organs; 1992 Jun; 16(3):291-3. PubMed ID: 10078261
[TBL] [Abstract][Full Text] [Related]
31. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
32. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
Nagata S; Glovsky MM
J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
[TBL] [Abstract][Full Text] [Related]
33. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
34. Normal pregnancy is characterized by systemic activation of the complement system.
Richani K; Soto E; Romero R; Espinoza J; Chaiworapongsa T; Nien JK; Edwin S; Kim YM; Hong JS; Mazor M
J Matern Fetal Neonatal Med; 2005 Apr; 17(4):239-45. PubMed ID: 16147832
[TBL] [Abstract][Full Text] [Related]
35. Anaphylatoxins C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyzer--an in vivo study.
Kandus A; Ponikvar R; Drinovec J; Kladnik S; Ivanovich P
Int J Artif Organs; 1990 Mar; 13(3):176-80. PubMed ID: 2347666
[TBL] [Abstract][Full Text] [Related]
36. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
[TBL] [Abstract][Full Text] [Related]
37. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
38. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.
Mack WJ; Ducruet AF; Hickman ZL; Garrett MC; Albert EJ; Kellner CP; Mocco J; Connolly ES
Neurosurgery; 2007 Aug; 61(2):255-60; discussion 260-1. PubMed ID: 17762737
[TBL] [Abstract][Full Text] [Related]
39. Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes.
Pan ZK
Biochim Biophys Acta; 1998 Nov; 1443(1-2):90-8. PubMed ID: 9838061
[TBL] [Abstract][Full Text] [Related]
40. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
